I have been running BPC-157 for two months and the honest summary is that the effect is smaller than the internet suggests and real.
Tolerance and underdosing look identical from the inside, which is why the answer is usually a blood test and not more forums.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
The measured outcome and the hoped-for outcome are rarely the same thing in these threads.
Happy to be corrected on any of the above.
Same here.
Loose evidence is not nothing, but a washout either side is the only reason to trust your own take.
How long before you can reasonably say something is or is not doing anything?
What is the first thing you would read if you were starting from zero?
What is the first thing you would read if you were starting from zero? Currently on BPC-157 myself.
Read methods.
Where does the human data stop and the extrapolation begin? That is the whole thread.
Most of what is called evidence here is one person, one vial, one month.
Reconstitution arithmetic is only half the problem. The other half is what was in the vial.
Narrow conclusion. Injection site reaction was my main issue with BPC-157 too.